• Je něco špatně v tomto záznamu ?

Potential for optimizing management of obesity in the secondary prevention of coronary heart disease

D. De Bacquer, CS. Jennings, E. Mirrakhimov, D. Lovic, J. Bruthans, D. De Smedt, N. Gotcheva, M. Dolzhenko, Z. Fras, N. Pogosova, S. Lehto, H. Hasan-Ali, P. Jankowski, K. Kotseva, G. De Backer, D. Wood, L. Rydén

. 2022 ; 8 (5) : 568-576. [pub] 2022Aug17

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024810

Grantová podpora
European Society of Cardiology

E-zdroje Online Plný text

NLK ProQuest Central od 2016-10-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2016-10-01 do Před 1 rokem

AIMS: Prevention guidelines have identified the management of obese patients as an important priority to reduce the burden of incident and recurrent cardiovascular disease. Still, studies have demonstrated that over 80% of patients with coronary heart disease (CHD) fail to achieve their weight target. Here, we describe advice received and actions reported by overweight CHD patients since being discharged from hospital and how weight changes relate to their risk profile. METHODS AND RESULTS: Based on data from 10 507 CHD patients participating in the EUROASPIRE IV and V studies, we analysed weight changes from hospital admission to the time of a study visit ≥6 and <24 months later. At hospitalization, 34.9% were obese and another 46.0% were overweight. Obesity was more frequent in women and associated with more comorbidities. By the time of the study visit, 19.5% of obese patients had lost ≥5% of weight. However, in 16.4% weight had increased ≥5%. Weight gain in those overweight was associated with physical inactivity, non-adherence to dietary recommendations, smoking cessation, raised blood pressure, dyslipidaemia, dysglycaemia, and lower levels of quality of life. Less than half of obese patients was considering weight loss in the coming month. CONCLUSIONS: The management of obesity remains a challenge in the secondary prevention of CHD despite a beneficial effect of weight loss on risk factor prevalences and quality of life. Cardiac rehabilitation programmes should include weight loss interventions as a specific component and the incremental value of telehealth intervention as well as recently described pharmacological interventions need full consideration.

Cardiology Department Singidunum University School of Medicine Clinic for Internal Disease Intermedica Jovana Ristica str 20 2 18000 Nis Serbia

Cardiovascular Medicine Department Assiut University Heart Hospital Assiut University Assiut University Campus 71515 Assiut Egypt

Centre for Cardiovascular Prevention 1st Faculty of Medicine and Thomayer Hospital Charles University Videnska 800 Prague 4 140 59 Czech Republic

Department of Cardiology and Internal Diseases Kyrgyz State Medical Academy Akhunbaev str 92 720020 Bishkek Kyrgyzstan

Department of Cardiology Interventional Electrocardiology and Hypertension Jagiellonian University Medical College 2 Jakubowski Str 30 688 Kraków Poland

Department of Internal Medicine Lapland Central Hospital Ounasrinteentie 22 96400 Rovaniemi Finland

Department of Medicine Solna Karolinska Institutet FoU Tema Hjärta och Kärl S1 02 Karolinska Universitetssjukhuset Solna SE 171 76 Stockholm Sweden

Department of Public Health and Primary Care Ghent University C Heymanslaan 10 6K3 entrance 42 B 9000 Ghent Belgium

Department of Vascular Medicine Division of Medicine University Medical Centre Ljubljana Zaloška 7 SI 1525 Ljubljana Slovenia

Imperial College Healthcare NHS Trust Praed Street London W2 1NY UK

Medical Faculty University of Ljubljana Vrazov trg 2 1000 Ljubljana Slovenia

National Centre of Cardiology and Internal Medicine Named After Academician Mirrakhimov MM Togolok Moldo str 3 720040 Bishkek Kyrgyzstan

National Heart and Lung Institute Imperial College London Guy Scadding Building Dovehouse St London SW3 6LY UK

National Heart Hospital Department of Cardiology Konjovitza str 65 1309 Sofia Bulgaria

National Institute for Prevention and Cardiovascular Health National University of Ireland Galway Croí Heart and Stroke Centre Croí House Moyola Lane Newcastle Galway H91 FF68 Ireland

National Medical Research Centre of Cardiology of the Ministry of Healthcare of the Russian Federation 3 rd Cherepkovskaya str 15A 121552 Moscow Russia

Shupyk National Medical Academy of Postgraduate Education Dorohozhytska 9 04112 Kyiv Ukraine

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024810
003      
CZ-PrNML
005      
20221031100043.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ehjqcco/qcab043 $2 doi
035    __
$a (PubMed)34315174
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a De Bacquer, Dirk $u Department of Public Health and Primary Care, Ghent University, C. Heymanslaan 10-6K3, entrance 42, B-9000 Ghent, Belgium $1 https://orcid.org/0000000232027238
245    10
$a Potential for optimizing management of obesity in the secondary prevention of coronary heart disease / $c D. De Bacquer, CS. Jennings, E. Mirrakhimov, D. Lovic, J. Bruthans, D. De Smedt, N. Gotcheva, M. Dolzhenko, Z. Fras, N. Pogosova, S. Lehto, H. Hasan-Ali, P. Jankowski, K. Kotseva, G. De Backer, D. Wood, L. Rydén
520    9_
$a AIMS: Prevention guidelines have identified the management of obese patients as an important priority to reduce the burden of incident and recurrent cardiovascular disease. Still, studies have demonstrated that over 80% of patients with coronary heart disease (CHD) fail to achieve their weight target. Here, we describe advice received and actions reported by overweight CHD patients since being discharged from hospital and how weight changes relate to their risk profile. METHODS AND RESULTS: Based on data from 10 507 CHD patients participating in the EUROASPIRE IV and V studies, we analysed weight changes from hospital admission to the time of a study visit ≥6 and <24 months later. At hospitalization, 34.9% were obese and another 46.0% were overweight. Obesity was more frequent in women and associated with more comorbidities. By the time of the study visit, 19.5% of obese patients had lost ≥5% of weight. However, in 16.4% weight had increased ≥5%. Weight gain in those overweight was associated with physical inactivity, non-adherence to dietary recommendations, smoking cessation, raised blood pressure, dyslipidaemia, dysglycaemia, and lower levels of quality of life. Less than half of obese patients was considering weight loss in the coming month. CONCLUSIONS: The management of obesity remains a challenge in the secondary prevention of CHD despite a beneficial effect of weight loss on risk factor prevalences and quality of life. Cardiac rehabilitation programmes should include weight loss interventions as a specific component and the incremental value of telehealth intervention as well as recently described pharmacological interventions need full consideration.
650    12
$a koronární nemoc $x komplikace $x epidemiologie $x prevence a kontrola $7 D003327
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a obezita $x komplikace $x epidemiologie $x terapie $7 D009765
650    12
$a nadváha $7 D050177
650    _2
$a kvalita života $7 D011788
650    _2
$a sekundární prevence $x metody $7 D055502
650    _2
$a hmotnostní úbytek $7 D015431
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jennings, Catriona S $u National Institute for Prevention and Cardiovascular Health, National University of Ireland - Galway, Croí Heart & Stroke Centre, Croí House, Moyola Lane, Newcastle, Galway H91 FF68, Ireland $u Imperial College Healthcare NHS Trust, Praed Street, London W2 1NY, UK
700    1_
$a Mirrakhimov, Erkin $u Department of Cardiology and Internal Diseases, Kyrgyz State Medical Academy, Akhunbaev str. 92, 720020, Bishkek, Kyrgyzstan $u National Centre of Cardiology and Internal Medicine Named After Academician Mirrakhimov MM, Togolok Moldo str. 3, 720040, Bishkek, Kyrgyzstan $1 https://orcid.org/0000000329826108
700    1_
$a Lovic, Dragan $u Cardiology Department, Singidunum University, School of Medicine, Clinic for Internal Disease Intermedica, Jovana Ristica str. 20/2, 18000 Nis, Serbia
700    1_
$a Bruthans, Jan $u Centre for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University, Videnska 800, Prague 4, 140 59, Czech Republic
700    1_
$a De Smedt, Delphine $u Department of Public Health and Primary Care, Ghent University, C. Heymanslaan 10-6K3, entrance 42, B-9000 Ghent, Belgium
700    1_
$a Gotcheva, Nina $u National Heart Hospital, Department of Cardiology, Konjovitza str. 65, 1309 Sofia, Bulgaria
700    1_
$a Dolzhenko, Maria $u Shupyk National Medical Academy of Postgraduate Education, Dorohozhytska 9, 04112, Kyiv, Ukraine
700    1_
$a Fras, Zlatko $u Department of Vascular Medicine, Division of Medicine, University Medical Centre Ljubljana, Zaloška 7, SI-1525 Ljubljana, Slovenia $u Medical Faculty, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia
700    1_
$a Pogosova, Nana $u National Medical Research Centre of Cardiology of the Ministry of Healthcare of the Russian Federation, 3-rd Cherepkovskaya str. 15A, 121552 Moscow, Russia $1 https://orcid.org/000000024165804X
700    1_
$a Lehto, Seppo $u Department of Internal Medicine, Lapland Central Hospital, Ounasrinteentie 22, 96400 Rovaniemi, Finland
700    1_
$a Hasan-Ali, Hasan $u Cardiovascular Medicine Department, Assiut University Heart Hospital, Assiut University, Assiut University Campus, 71515 Assiut, Egypt
700    1_
$a Jankowski, Piotr $u Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, 2 Jakubowski Str., 30-688 Kraków, Poland
700    1_
$a Kotseva, Kornelia $u National Institute for Prevention and Cardiovascular Health, National University of Ireland - Galway, Croí Heart & Stroke Centre, Croí House, Moyola Lane, Newcastle, Galway H91 FF68, Ireland $u Imperial College Healthcare NHS Trust, Praed Street, London W2 1NY, UK
700    1_
$a De Backer, Guy $u Department of Public Health and Primary Care, Ghent University, C. Heymanslaan 10-6K3, entrance 42, B-9000 Ghent, Belgium
700    1_
$a Wood, David $u National Institute for Prevention and Cardiovascular Health, National University of Ireland - Galway, Croí Heart & Stroke Centre, Croí House, Moyola Lane, Newcastle, Galway H91 FF68, Ireland $u National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse St, London SW3 6LY, UK
700    1_
$a Rydén, Lars $u Department of Medicine, Solna, Karolinska Institutet, FoU - Tema Hjärta och Kärl, S1:02, Karolinska Universitetssjukhuset/Solna, SE-171 76, Stockholm, Sweden
773    0_
$w MED00200141 $t European heart journal. Quality of care & clinical outcomes $x 2058-1742 $g Roč. 8, č. 5 (2022), s. 568-576
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34315174 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100041 $b ABA008
999    __
$a ok $b bmc $g 1854504 $s 1176100
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 8 $c 5 $d 568-576 $e 2022Aug17 $i 2058-1742 $m European heart journal. Quality of care & clinical outcomes $n Eur Heart J Qual Care Clin Outcomes $x MED00200141
GRA    __
$p European Society of Cardiology
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...